{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,13]],"date-time":"2023-10-13T07:41:45Z","timestamp":1697182905943},"reference-count":20,"publisher":"Japanese Society of Internal Medicine","issue":"9","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Intern. Med."],"published-print":{"date-parts":[[2005]]},"DOI":"10.2169\/internalmedicine.44.949","type":"journal-article","created":{"date-parts":[[2005,10,28]],"date-time":"2005-10-28T05:57:45Z","timestamp":1130479065000},"page":"949-953","source":"Crossref","is-referenced-by-count":8,"title":["Development of Hepatocellular Carcinoma in a Woman with HBV- and HCV-negative Autoimmune Hepatitis with Unsatisfactory Response to Corticosteroid"],"prefix":"10.2169","volume":"44","author":[{"given":"Yasuhiro","family":"MIYAKE","sequence":"first","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine and Dentistry, Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kohsaku","family":"SAKAGUCHI","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine and Dentistry, Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hironori","family":"TANAKA","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine and Dentistry, Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shinichiro","family":"NAKAMURA","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine and Dentistry, Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiyuki","family":"KOBAYASHI","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine and Dentistry, Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shin-ichi","family":"FUJIOKA","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine and Dentistry, Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yoshiaki","family":"IWASAKI","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine and Dentistry, Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yasushi","family":"SHIRATORI","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology & Hepatology, Okayama University Graduate School of Medicine and Dentistry, Okayama"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"962","reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"1) Czaja AJ. Natural history, clinical features, and treatment of autoimmune hepatitis. Semin Liver Dis <b>4<\/b>: 1-12, 1984.","DOI":"10.1055\/s-2008-1040641"},{"key":"2","doi-asserted-by":"crossref","unstructured":"2) Toda G, Zeniya M, Watanabe F, et al. Present status of autoimmune hepatitis in Japan&mdash;correlating the characteristics with international criteria in an area with a high rate of HCV infection. Japanese National Study Group of Autoimmune Hepatitis. J Hepatol <b>26<\/b>: 1207-1212, 1997.","DOI":"10.1016\/S0168-8278(97)80453-9"},{"key":"3","doi-asserted-by":"crossref","unstructured":"3) Wang KK, Czaja AJ. Hepatocellular carcinoma in corticosteroid-treated severe autoimmune chronic active hepatitis. Hepatology <b>8<\/b>: 1679-1683, 1988.","DOI":"10.1002\/hep.1840080635"},{"key":"4","unstructured":"4) Ryder SD, Koskinas J, Rizzi PM, et al. Hepatocellular carcinoma complicating autoimmune hepatitis: role of hepatitis C virus. Hepatology <b>22<\/b>: 718-722, 1995."},{"key":"5","doi-asserted-by":"crossref","unstructured":"5) Park SZ, Nagorney DM, Czaja AJ. Hepatocellular carcinoma in autoimmune hepatitis. Dig Dis Sci <b>45<\/b>: 1944-1948, 2000.","DOI":"10.1023\/A:1005638500236"},{"key":"6","doi-asserted-by":"crossref","unstructured":"6) Yamazaki K, Kamiyama T, Shiba S, et al. An aged male patient with autoimmune hepatitis complicated by hepatocellular carcinoma. Intern Med <b>38<\/b>: 422-425, 1999.","DOI":"10.2169\/internalmedicine.38.422"},{"key":"7","doi-asserted-by":"crossref","unstructured":"7) Watanabe M, Moritani M, Hamamoto S, et al. Hepatocellular carcinoma complicating HCV-negative autoimmune hepatitis without corticosteroid therapy. J Clin Gastroenterol <b>30<\/b>: 445-446, 2000.","DOI":"10.1097\/00004836-200006000-00020"},{"key":"8","doi-asserted-by":"crossref","unstructured":"8) Hori K, Fukuda Y, Tomita T, et al. Hepatocellular carcinoma complicating autoimmune hepatitis without either hepatitis C viral infection or corticosteroid therapy. J Gastroenterol <b>38<\/b>: 197-199, 2003.","DOI":"10.1007\/s005350300034"},{"key":"9","doi-asserted-by":"crossref","unstructured":"9) Hino T, Kumashiro R, Ide T, et al. Autoimmune Hepatitis Study Group. Predictive factors for remission and death in 73 patients with autoimmune hepatitis in Japan. Int J Mol Med <b>11<\/b>: 749-755, 2003.","DOI":"10.3892\/ijmm.11.6.749"},{"key":"10","doi-asserted-by":"crossref","unstructured":"10) Hardee JT, Breth GF, El-Serag HB. Hepatocellular carcinoma associated with autoimmune hepatitis. J Clin Gastroenterol <b>37<\/b>: 271-272, 2003.","DOI":"10.1097\/00004836-200309000-00017"},{"key":"11","doi-asserted-by":"crossref","unstructured":"11) Sakaguchi T, Nakamura S, Suzuki S, et al. Hepatocellular carcinoma associated with lupoid hepatitis: a review of Japanese reports. Surg Today <b>25<\/b>: 838-842, 1995.","DOI":"10.1007\/BF00311464"},{"key":"12","doi-asserted-by":"crossref","unstructured":"12) Nishiyama R, Kanai T, Abe J, et al. Hepatocellular carcinoma associated with autoimmune hepatitis. J Hepatobiliary Pancreat Surg <b>11<\/b>: 215-219, 2004.","DOI":"10.1007\/s00534-003-0878-z"},{"key":"13","doi-asserted-by":"crossref","unstructured":"13) Fujioka S, Shimomura H, Iwasaki Y, et al. Hepatitis B virus gene in liver tissue promotes hepatocellular carcinoma development in chronic hepatitis C patients. Dig Dis Sci <b>48<\/b>: 1920-1924, 2003.","DOI":"10.1023\/A:1026153800896"},{"key":"14","doi-asserted-by":"crossref","unstructured":"14) Clifford BD, Donahue D, Smith L, et al. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology <b>21<\/b>: 613-619, 1995.","DOI":"10.1002\/hep.1840210302"},{"key":"15","doi-asserted-by":"crossref","unstructured":"15) Cassani F, Cataleta M, Valentini P, et al. Serum autoantibodies in chronic hepatitis C: comparison with autoimmune hepatitis and impact on the disease profile. Hepatology <b>26<\/b>: 561-566, 1997.","DOI":"10.1002\/hep.510260305"},{"key":"16","doi-asserted-by":"crossref","unstructured":"16) Kumada H. Long-term treatment of chronic hepatitis C with glycyrrhizin [stronger neo-minophagen C (SNMC)] for preventing liver cirrhosis and hepatocellular carcinoma. Oncology <b>62<\/b> Suppl 1: 94-100, 2002.","DOI":"10.1159\/000048283"},{"key":"17","doi-asserted-by":"crossref","unstructured":"17) Kashiwagi K, Furusyo N, Kubo N, et al. A prospective comparison of the effect of interferon-alpha and interferon-beta treatment in patients with chronic hepatitis C on the incidence of hepatocellular carcinoma development. J Infect Chemother <b>9<\/b>: 333-340, 2003.","DOI":"10.1007\/s10156-003-0271-5"},{"key":"18","doi-asserted-by":"crossref","unstructured":"18) Pollicino T, Squadrito G, Cerenzia G, et al. Hepatitis B virus maintains its pro-oncogenic properties in the case of occult HBV infection. Gastroenterology <b>126<\/b>: 102-110, 2004.","DOI":"10.1053\/j.gastro.2003.10.048"},{"key":"19","doi-asserted-by":"crossref","unstructured":"19) Wang KK, Czaja AJ. Hepatocellular carcinoma in corticosteroid-treated severe autoimmune chronic active hepatitis. Hepatology <b>8<\/b>: 1679-1683, 1988.","DOI":"10.1002\/hep.1840080635"},{"key":"20","doi-asserted-by":"crossref","unstructured":"20) Roberts SK, Therneau TM, Czaja AJ. Prognosis of histological cirrhosis in type 1 autoimmune hepatitis. Gastroenterology <b>110<\/b>: 848-857, 1996.","DOI":"10.1053\/gast.1996.v110.pm8608895"}],"container-title":["Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/9\/44_9_949\/_pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,4,10]],"date-time":"2020-04-10T14:41:37Z","timestamp":1586529697000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.jstage.jst.go.jp\/article\/internalmedicine\/44\/9\/44_9_949\/_article"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005]]},"references-count":20,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2005]]}},"URL":"https:\/\/doi.org\/10.2169\/internalmedicine.44.949","relation":{},"ISSN":["0918-2918","1349-7235"],"issn-type":[{"value":"0918-2918","type":"print"},{"value":"1349-7235","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005]]}}}